PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
52.59
-0.21 (-0.40%)
Mar 7, 2025, 4:00 PM EST - Market closed
PTC Therapeutics Employees
PTC Therapeutics had 939 employees as of December 31, 2024. The number of employees decreased by 116 or -11.00% compared to the previous year.
Employees
939
Change (1Y)
-116
Growth (1Y)
-11.00%
Revenue / Employee
$859,191
Profits / Employee
-$386,896
Market Cap
4.15B
Employees Chart
Employees History
PTCT News
- 21 hours ago - PTC Therapeutics: Upside In Rare Disease Innovation - Seeking Alpha
- 10 days ago - PTC Therapeutics, Inc. (PTCT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 17 days ago - PTC Therapeutics to Participate in Upcoming Investor Conferences - PRNewsWire
- 18 days ago - PTC Therapeutics Announces FDA Acceptance and Priority Review for Vatiquinone NDA for the Treatment of Children and Adults with Friedreich's Ataxia - PRNewsWire
- 24 days ago - PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 7 weeks ago - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 7 weeks ago - PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire